<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">317310</id>
  <title nil="true"/>
  <common-name>2-[hydroxy-[(2r,3s,4s)-2,3,4-trihydroxy-5-(2,4,8-trioxo-1h-pyrimido[4,5-b]quinolin-10-yl)pentoxy]phosphoryl]oxyprop-2-enoic acid</common-name>
  <description>2-[hydroxy-[(2r,3s,4s)-2,3,4-trihydroxy-5-(2,4,8-trioxo-1h-pyrimido[4,5-b]quinolin-10-yl)pentoxy]phosphoryl]oxyprop-2-enoic acid has the chemical formula C19H20N3O12P. With an average molecular weight of 513.30 g/mol, 2-[hydroxy-[(2r,3s,4s)-2,3,4-trihydroxy-5-(2,4,8-trioxo-1h-pyrimido[4,5-b]quinolin-10-yl)pentoxy]phosphoryl]oxyprop-2-enoic acid is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>138388128</pubchem-id>
  <chemical-formula>C19H20N3O12P</chemical-formula>
  <weight>513.3</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-29T15:23:44Z</created-at>
  <updated-at type="dateTime">2026-08-29T15:23:44Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C=C(C(=O)O)OP(=O)(O)OCC(C(C(CN1C2=CC(=O)C=CC2=CC3=C1NC(=O)NC3=O)O)O)O</moldb-smiles>
  <moldb-formula>C19H20N3O12P</moldb-formula>
  <moldb-inchi>InChI=1S/C19H20N3O12P/c1-8(18(28)29)34-35(31,32)33-7-14(25)15(26)13(24)6-22-12-5-10(23)3-2-9(12)4-11-16(22)20-19(30)21-17(11)27/h2-5,13-15,24-26H,1,6-7H2,(H,28,29)(H,31,32)(H2,20,21,27,30)/t13-,14+,15-/m0/s1</moldb-inchi>
  <moldb-inchikey>VXQYYXJOSRZXMW-ZNMIVQPWSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">513.0784601</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>-3</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM313203</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-[hydroxy-[(2r,3s,4s)-2,3,4-trihydroxy-5-(2,4,8-trioxo-1h-pyrimido[4,5-b]quinolin-10-yl)pentoxy]phosphoryl]oxyprop-2-enoic acid</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom nil="true"/>
  <superklass nil="true"/>
  <klass nil="true"/>
  <subklass nil="true"/>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0268134</sync-id>
  <structure-inchikey>VXQYYXJOSRZXMW-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>40000100000000020000800000000200000000000000000080000000100000000000000000004021000000020000000004000000000000020000000002000000000000000010000000000000000000000020000000000100003000000002000080050000211000040000000800100080800000000100200000000800000000020000000000000000000000220400000000800800000000000000000000000000000000000004000000040201080040000000000200800000000000002000000000000000000000000000000000008000000000080000081000004200000000000000000000020000000040000000000420000000000000000000080000200001</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAjAAAAJQAAAIABBgBoAAAAAwICBgAoAAAA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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:23:11Z</structure-indexed-at>
</compound>
